| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |